| For: | Zhi YH, Liu RS, Song MM, Tian Y, Long J, Tu W, Guo RX. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3724-3728 [PMID: 15968728 DOI: 10.3748/wjg.v11.i24.3724] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i24/3724.htm |
| Number | Citing Articles |
| 1 |
Pablo Letelier, Patricia Garcia, Pamela Leal, Carmen Ili, Kurt Buchegger, Ismael Riquelme, Alejandra Sandoval, Oscar Tapia, Juan C. Roa. Immunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2014; 22(7) doi: 10.1097/PAI.0b013e3182a318a9
|
| 2 |
Bujung Hong, Makoto Nakamura, Joachim K. Krauss. Tumors of the Central Nervous System, Volume 13. Tumors of the Central Nervous System 2014; 13 doi: 10.1007/978-94-007-7602-9_5
|
| 3 |
Weiqin Lu, Aihemaitijiang Aihaiti, Paziliya Abudukeranmu, Yajun Liu, Huihui Gao. Arachidonic acid metabolism as a novel pathogenic factor in gastrointestinal cancers. Molecular and Cellular Biochemistry 2025; 480(2) doi: 10.1007/s11010-024-05057-2
|
| 4 |
Kyoung-Bun Lee. Histologic and Molecular Pathogenesis of Gallbladder Cancer. The Korean Journal of Pancreas and Biliary Tract 2018; 23(1) doi: 10.15279/kpba.2018.23.1.1
|
| 5 |
Takahiro Naruse, Yukihiro Matsuyama, Naoki Ishiguro. Cyclooxygenase-2 expression in ependymoma of the spinal cord. Journal of Neurosurgery: Spine 2007; 6(3) doi: 10.3171/spi.2007.6.3.240
|
| 6 |
E. M. Elia, D. Belgorosky, M. Faut, S. Vighi, C. Pustovrh, D. Luigi, A. B. Motta. The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice. Molecular Human Reproduction 2009; 15(7) doi: 10.1093/molehr/gap033
|
| 7 |
Sanjeev K. Maurya, Mallika Tewari, Raghvendra R. Mishra, Hari S. Shukla. Genetic abberations in gallbladder cancer. Surgical Oncology 2012; 21(1) doi: 10.1016/j.suronc.2010.09.003
|
| 8 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_148-1
|
| 9 |
Yumin Li, Junqiang Zhang, Haizhen Ma. Chronic inflammation and gallbladder cancer. Cancer Letters 2014; 345(2) doi: 10.1016/j.canlet.2013.08.034
|
| 10 |
Monika Vishnoi, Sachchida Nand Pandey, Dinesh Raj Modi, Ashok Kumar, Balraj Mittal. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor β1 -509C>T gene polymorphisms with gallbladder cancer. Human Immunology 2008; 69(6) doi: 10.1016/j.humimm.2008.04.004
|
| 11 |
Munita Meenu Bal, Mukta Ramadwar, Kedar Deodhar, Shailesh Shrikhande. Pathology of Gallbladder Carcinoma: Current Understanding and New Perspectives. Pathology & Oncology Research 2015; 21(3) doi: 10.1007/s12253-014-9886-3
|
| 12 |
Manjusha Dixit, Vinay J, Soham Choudhury. Gallbladder Cancer. 2023; doi: 10.1007/978-981-19-6442-8_16
|
| 13 |
Elizabeth P. Ryan, Timothy P. Bushnell, Alan E. Friedman, Irfan Rahman, Richard P. Phipps. Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells. Cancer Immunology, Immunotherapy 2008; 57(3) doi: 10.1007/s00262-007-0374-4
|
| 14 |
ZHE LONG LIANG, MEERAN KIM, SONG MEI HUANG, HYO JIN LEE, JIN-MAN KIM. Expression of carboxyl terminus of Hsp70-interacting protein (CHIP) indicates poor prognosis in human gallbladder carcinoma. Oncology Letters 2013; 5(3) doi: 10.3892/ol.2013.1138
|
| 15 |
Claudia Bocca, Francesca Bozzo, Stefania Cannito, Maurizio Parola, Antonella Miglietta. Celecoxib inactivates epithelial–mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells. Molecular Carcinogenesis 2012; 51(10) doi: 10.1002/mc.20846
|
| 16 |
Hee Jung Kim, Ga Won Yim, Eun Ji Nam, Young Tae Kim. Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. Cancer Research and Treatment 2014; 46(1) doi: 10.4143/crt.2014.46.1.81
|
| 17 |
Sung-Im Do, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim. Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder Carcinoma. The Korean Journal of Pathology 2010; 44(1) doi: 10.4132/KoreanJPathol.2010.44.1.42
|
| 18 |
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancer. Expert Opinion on Emerging Drugs 2007; 12(4) doi: 10.1517/14728214.12.4.571
|
| 19 |
Byung Hoon Kim, Chun Il Kim, Hyuk Soo Chang, Mi Sun Choe, Hye Ra Jung, Duk Yoon Kim, Choal Hee Park. Cyclooxygenase-2 Overexpression in Chronic Inflammation Associated with Benign Prostatic Hyperplasia: Is It Related to Apoptosis and Angiogenesis of Prostate Cancer?. Korean Journal of Urology 2011; 52(4) doi: 10.4111/kju.2011.52.4.253
|
| 20 |
Alphonse E Sirica. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2008; 14(46): 7033-7058 doi: 10.3748/wjg.14.7033
|
| 21 |
A. Giatromanolaki, E. Sivridis, C. Simopoulos, A. Polychronidis, K.C. Gatter, A.L. Harris, M.I. Koukourakis. Hypoxia inducible factors 1α and 2α are associated with VEGF expression and angiogenesis in gallbladder carcinomas. Journal of Surgical Oncology 2006; 94(3) doi: 10.1002/jso.20443
|
| 22 |
Helen P.S. Wong, Judy W.C. Ho, Marcel W.L. Koo, Le Yu, William K.K. Wu, Emily K.Y. Lam, Emily K.K. Tai, Joshua K.S. Ko, Vivian Y. Shin, Kent Man Chu, Chi Hin Cho. Effects of adrenaline in human colon adenocarcinoma HT-29 cells. Life Sciences 2011; 88(25-26) doi: 10.1016/j.lfs.2011.04.007
|
| 23 |
Seok‐Woo Park, Hyo‐Sun Kim, Jeong‐Hun Hah, Kwang‐Hyun Kim, Dae‐Seog Heo, Myung‐Whun Sung. Differential effects between cyclooxygenase‐2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell lines. Head & Neck 2010; 32(11) doi: 10.1002/hed.21362
|
| 24 |
Robert David Goldin, Juan Carlos Roa. Gallbladder cancer: a morphological and molecular update. Histopathology 2009; 55(2) doi: 10.1111/j.1365-2559.2008.03192.x
|
| 25 |
Haeryoung Kim, Joo-Yeon Song, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han, Hye Seung Lee, Han Suk Ryu, Gheeyoung Choe. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. Journal of Clinical Pathology 2010; 63(12) doi: 10.1136/jcp.2010.080713
|
| 26 |
Imran Khan, Monika Bhardwaj, Shruti Shukla, Hoomin Lee, Mi-Hwa Oh, Vivek K. Bajpai, Yun Suk Huh, Sun Chul Kang. Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model. Colloids and Surfaces B: Biointerfaces 2019; 181 doi: 10.1016/j.colsurfb.2019.06.016
|
| 27 |
Armin Thelen, Arne Scholz, Wilko Weichert, Bertram Wiedenmann, Peter Neuhaus, Reinhard Geßner, Christoph Benckert, Sven Jonas. Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma. American Journal of Gastroenterology 2010; 105(5) doi: 10.1038/ajg.2009.674
|
| 28 |
Bujung Hong, Claudia A Krusche, Kerstin Schwabe, Sabrina Friedrich, Rüdiger Klein, Joachim K Krauss, Makoto Nakamura. Cyclooxygenase-2 Supports Tumor Proliferation in Vestibular Schwannomas. Neurosurgery 2011; 68(4) doi: 10.1227/NEU.0b013e318208f5c7
|
| 29 |
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt, Andrej Cör. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions. World Journal of Gastroenterology 2006; 12(21): 3425-3429 doi: 10.3748/wjg.v12.i21.3425
|
| 30 |
Chih-Long Chang, Barbara Ma, Xiaowu Pang, T-C Wu, Chien-Fu Hung. Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian Cancer. Molecular Therapy 2009; 17(8) doi: 10.1038/mt.2009.118
|
| 31 |
Ki Won Lee, Joydeb Kumar Kundu, Sue Ok Kim, Kyung-Soo Chun, Hyong Joo Lee, Young-Joon Surh. Cocoa Polyphenols Inhibit Phorbol Ester-Induced Superoxide Anion Formation in Cultured HL-60 Cells and Expression of Cyclooxygenase-2 and Activation of NF-κB and MAPKs in Mouse Skin In Vivo. The Journal of Nutrition 2006; 136(5) doi: 10.1093/jn/136.5.1150
|
| 32 |
Vivian Y. Shin, William K.K. Wu, Kent-Man Chu, Helen P.S. Wong, Emily K.Y. Lam, Emily K.K. Tai, Marcel W.L. Koo, Chi-Hin Cho. Nicotine Induces Cyclooxygenase-2 and Vascular Endothelial Growth Factor Receptor-2 in Association with Tumor-Associated Invasion and Angiogenesis in Gastric Cancer. Molecular Cancer Research 2005; 3(11) doi: 10.1158/1541-7786.MCR-05-0106
|
| 33 |
Huifang Yang, Yiran Wang, Yilin Wang, Kexin Tang, Jing Guo, Tong Li. A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapy. Journal of Materials Science: Materials in Medicine 2025; 36(1) doi: 10.1007/s10856-025-06968-2
|
| 34 |
C. Pepper, J. G. Mahdi, A. G. S. Buggins, S. Hewamana, E. Walsby, E. Mahdi, A. Al-Haza’a, A. J. Mahdi, T. T. Lin, L. Pearce, L. Morgan, I. D. Bowen, P. Brennan, C. Fegan. Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation 2011; 44(4) doi: 10.1111/j.1365-2184.2011.00760.x
|
| 35 |
Jeremy A Lombardo, Derek A Banyard, David Zalazar, Mary Ziegler, Alexandria M Sorensen, Pisrut Phummirat, Alan D Widgerow, Jered B Haun. Mechanical Processing of Lipoaspirate With a Fluidic Device Platform Promotes Wound Healing Transcriptional Programs and Angiogenesis In Vitro. Aesthetic Surgery Journal 2025; 45(8) doi: 10.1093/asj/sjaf055
|
| 36 |
Mehmet ßahin, Emel ßahin, Saadet Gümüşlü. Cyclooxygenase-2 in Cancer and Angiogenesis. Angiology 2009; 60(2) doi: 10.1177/0003319708318378
|
| 37 |
Sharon Weber, William Jarnagin, Austin Duffy, Eileen M. O'Reilly, Ghassan K. Abou-Alfa, Leslie Blumgart. Abeloff's Clinical Oncology. 2008; doi: 10.1016/B978-0-443-06694-8.50088-9
|
| 38 |
P. Baichan, P. Naicker, J. W. S. Devar, M. Smith, G. P. Candy, E. Nweke. Targeting gallbladder cancer: a pathway based perspective. Molecular Biology Reports 2020; 47(3) doi: 10.1007/s11033-020-05269-x
|
| 39 |
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis. Scandinavian Journal of Gastroenterology 2009; 44(9) doi: 10.1080/00365520903121685
|
| 40 |
Juan Carlos Roa, Nora Katabi, N. Volkan Adsay. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5 doi: 10.1007/978-1-4419-7107-4_61
|
| 41 |
Eric I Marks, Nelson S Yee. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World Journal of Gastroenterology 2016; 22(4): 1335-1347 doi: 10.3748/wjg.v22.i4.1335
|
| 42 |
Juuso H. Taskinen, Minna Holopainen, Hanna Ruhanen, Miesje van der Stoel, Reijo Käkelä, Elina Ikonen, Salla Keskitalo, Markku Varjosalo, Vesa M. Olkkonen. Functional omics of ORP7 in primary endothelial cells. BMC Biology 2024; 22(1) doi: 10.1186/s12915-024-02087-6
|
| 43 |
Alphonse E. Sirica, Zichen Zhang, Guan‐Hua Lai, Toru Asano, Xue‐Ning Shen, Deanna J. Ward, Arvind Mahatme, Jennifer L. DeWitt. A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡. Hepatology 2008; 47(4) doi: 10.1002/hep.22088
|
| 44 |
Melanie B Thomas. Targeted therapies for cancer of the gallbladder. Current Opinion in Gastroenterology 2008; 24(3) doi: 10.1097/MOG.0b013e3282f6a7df
|
| 45 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_148
|